501 related articles for article (PubMed ID: 22323414)
21. INSULIN TIMING: A PATIENT-CENTERED APPROACH TO IMPROVE CONTROL IN TYPE 1 DIABETES.
Duran-Valdez E; Burge MR; Broderick P; Shey L; Valentine V; Schrader RM; Schade DS
Endocr Pract; 2017 Apr; 23(4):471-478. PubMed ID: 28156154
[TBL] [Abstract][Full Text] [Related]
22. Switching from Flash Glucose Monitoring to Continuous Glucose Monitoring on Hypoglycemia in Adults with Type 1 Diabetes at High Hypoglycemia Risk: The Extension Phase of the I HART CGM Study.
Reddy M; Jugnee N; Anantharaja S; Oliver N
Diabetes Technol Ther; 2018 Nov; 20(11):751-757. PubMed ID: 30265562
[TBL] [Abstract][Full Text] [Related]
23. Striving for control: lessons learned from a successful international Type 1 Diabetes Youth Challenge.
Kordonouri O; Vazeou A; Scharf M; Würsig M; Battelino T;
Acta Diabetol; 2017 Apr; 54(4):403-409. PubMed ID: 28154987
[TBL] [Abstract][Full Text] [Related]
24. Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
Oriot P; Hermans MP
J Diabetes Complications; 2023 Feb; 37(2):108385. PubMed ID: 36603333
[TBL] [Abstract][Full Text] [Related]
25. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study.
Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C
Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293
[TBL] [Abstract][Full Text] [Related]
26. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
[TBL] [Abstract][Full Text] [Related]
27. Optimization of Insulin Regimen and Glucose Outcomes with Short-Term Real-Time Continuous Glucose Monitoring in Adult Type 1 Diabetes Patients with Suboptimal Control on Multiple Daily Injections: The Adult DIACCOR Study.
Picard S; Hanaire H; Reznik Y; Benhamou PY; Fendri S; Dufaitre L; Leutenegger E; Guerci B
Diabetes Technol Ther; 2018 Jun; 20(6):403-412. PubMed ID: 29847735
[TBL] [Abstract][Full Text] [Related]
28. Lack of association between residual insulin production and glucagon response to hypoglycemia in youth with short duration of type 1 diabetes.
Sherr J; Xing D; Ruedy KJ; Beck RW; Kollman C; Buckingham B; White NH; Fox L; Tsalikian E; Weinzimer S; Arbelaez AM; Tamborlane WV;
Diabetes Care; 2013 Jun; 36(6):1470-6. PubMed ID: 23288858
[TBL] [Abstract][Full Text] [Related]
29. The impact of continuous glucose monitoring on low interstitial glucose values and low blood glucose values assessed by point-of-care blood glucose meters: results of a crossover trial.
Hermanns N; Schumann B; Kulzer B; Haak T
J Diabetes Sci Technol; 2014 May; 8(3):516-22. PubMed ID: 24876615
[TBL] [Abstract][Full Text] [Related]
30. Restoration of self-awareness of hypoglycemia in adults with long-standing type 1 diabetes: hyperinsulinemic-hypoglycemic clamp substudy results from the HypoCOMPaSS trial.
Leelarathna L; Little SA; Walkinshaw E; Tan HK; Lubina-Solomon A; Kumareswaran K; Lane AP; Chadwick T; Marshall SM; Speight J; Flanagan D; Heller SR; Shaw JA; Evans ML
Diabetes Care; 2013 Dec; 36(12):4063-70. PubMed ID: 24130355
[TBL] [Abstract][Full Text] [Related]
31. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial.
Stewart ZA; Wilinska ME; Hartnell S; O'Neil LK; Rayman G; Scott EM; Barnard K; Farrington C; Hovorka R; Murphy HR
Diabetes Care; 2018 Jul; 41(7):1391-1399. PubMed ID: 29535135
[TBL] [Abstract][Full Text] [Related]
32. The role of glycemia in insulin resistance in youth with type 1 and type 2 diabetes.
Chan CL; Pyle L; Morehead R; Baumgartner A; Cree-Green M; Nadeau KJ
Pediatr Diabetes; 2017 Sep; 18(6):470-477. PubMed ID: 27503277
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
Nicolucci A; Rossi MC; D'Ostilio D; Delbaere A; de Portu S; Roze S
Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):707-715. PubMed ID: 29753586
[TBL] [Abstract][Full Text] [Related]
34. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
Hirsch IB; Abelseth J; Bode BW; Fischer JS; Kaufman FR; Mastrototaro J; Parkin CG; Wolpert HA; Buckingham BA
Diabetes Technol Ther; 2008 Oct; 10(5):377-83. PubMed ID: 18715214
[TBL] [Abstract][Full Text] [Related]
35. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
[TBL] [Abstract][Full Text] [Related]
36. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
[TBL] [Abstract][Full Text] [Related]
37. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
[TBL] [Abstract][Full Text] [Related]
38. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
[TBL] [Abstract][Full Text] [Related]
39. Treatment recommendations following 3-day masked continuous glucose monitoring (CGM) in youth with type 1 diabetes.
Rasbach LE; Atkins AE; Milaszewski KM; Keady J; Schmidt LM; Volkening LK; Laffel LM
J Diabetes Sci Technol; 2014 May; 8(3):494-7. PubMed ID: 24876612
[TBL] [Abstract][Full Text] [Related]
40. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
